Literature DB >> 7511819

Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.

H Gomi1, Y Tagaya, T Nakano, T Mikayama, K Ishizaka.   

Abstract

We obtained human T-cell hybridomas that are specific for bee venom phospholipase A2 (PLA2) and constitutively secrete glycosylation inhibiting factor (GIF). Upon crosslinking of CD3, the hybridoma produced GIF having affinity for PLA2. When affinity-purified PLA2-binding GIF was used as an immunogen, monoclonal antibodies specific for the antigen-binding GIF were obtained. Monoclonal antibody 110BH3 bound the antigen-binding GIF but failed to bind the 13-kDa nonspecific GIF, as determined by both bioassay and ELISA. In contrast, 388F1, a monoclonal antibody against nonspecific GIF, gave ELISA signals with both the nonspecific GIF and the antigen-binding GIF. Gel filtration of affinity-purified antigen-binding GIF revealed the presence of a 72- to 80-kDa protein which gave ELISA signals with both 110BH3 and 388F1 and contained GIF bioactivity. Upon reduction and alkylation, the antigen-binding GIF dissociated into a 62- to 64-kDa protein which gave positive ELISA with antibody 110BH3 but no signal with antibody 388F1, and a 15-kDa protein, which gave ELISA signal with the 388F1 but not with 110BH3. Immunoblotting of a PLA2-binding GIF preparation revealed that under reducing conditions, the antigen-binding GIF dissociated a 13-kDa peptide which reacted with polyclonal antibodies against recombinant GIF. The results indicate that the 13-kDa nonspecific GIF is a subunit of antigen-binding GIF. The PLA2-binding GIF has affinity for an epitope, representing amino acid residues 19-28 in PLA2 which appears to be an external structure in the antigen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511819      PMCID: PMC43463          DOI: 10.1073/pnas.91.7.2824

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells.

Authors:  P Marrack; J Kappler
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

2.  Structural analyses of a monoclonal heterodimeric suppressor factor specific for L-glutamic acid60-L-alanine30-L-tyrosine10.

Authors:  C W Turck; J A Kapp; D R Webb
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The biochemistry of antigen-specific T-cell factors.

Authors:  D R Webb; J A Kapp; C W Pierce
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines.

Authors:  H Spits; G Keizer; J Borst; C Terhorst; A Hekman; J E de Vries
Journal:  Hybridoma       Date:  1983

6.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

7.  Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen.

Authors:  H Yasueda; Y Yui; T Shimizu; T Shida
Journal:  J Allergy Clin Immunol       Date:  1983-01       Impact factor: 10.793

8.  Enzyme amplification can enhance both the speed and the sensitivity of immunoassays.

Authors:  C J Stanley; A Johannsson; C H Self
Journal:  J Immunol Methods       Date:  1985-10-24       Impact factor: 2.303

9.  Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.

Authors:  P Jardieu; M Akasaki; K Ishizaka
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

10.  Analysis of T cell hybridomas. II. Comparisons among three distinct types of monoclonal suppressor factors.

Authors:  K Okuda; M Minami; M Furusawa; M E Dorf
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  3 in total

1.  Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.

Authors:  Y C Liu; T Nakano; C Elly; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

2.  Molecular cloning and characterization of a cDNA encoding monoclonal nonspecific suppressor factor.

Authors:  M Nakamura; R M Xavier; T Tsunematsu; Y Tanigawa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

3.  Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.

Authors:  T Nakano; Y C Liu; T Mikayama; H Watarai; M Taniguchi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.